Orbital Decompression for Thyroid Eye Disease
On this page
Direct answer
Orbital decompression removes fat or bone from the orbit to relieve the crowding that thyroid eye disease creates — swollen extraocular muscles and fat inside fixed bony walls — and it is reserved for patients with compressive optic neuropathy at the orbital apex, severe exposure keratopathy, or disfiguring proptosis in the burnt-out phase. The medical pathway comes first where applicable — smoking cessation, selenium for mild disease, intravenous methylprednisolone pulses by EUGOGO protocols, and newer IGF-1R antibodies — but decompression is the definitive answer when sight is choking. Wall selection trades proptosis reduction against diplopia, with balanced medial-lateral decompression reducing new squint; and the reconstructive sequence is fixed: decompression first, strabismus surgery second, eyelid surgery last.
What you must remember
- The two sight-threatening emergencies: dysthyroid (compressive) optic neuropathy — apical crowding by enlarged inferior and medial recti choking the optic nerve, with colour desaturation and visual field loss preceding acuity fall — and exposure keratopathy from severe proptosis and lid retraction; both override the activity phase.
- Staging the disease: EUGOGO severity grading (sight-threatening, moderate-to-severe, mild) and Clinical Activity Score for inflammation; active disease is treated medically, burnt-out disease surgically — except decompression for optic neuropathy, which may be needed even in the active phase.
- Medical ladder: smoking cessation (the strongest modifiable factor), selenium for mild European cohorts, intravenous methylprednisolone (cumulative dose around 4.5 g in standard EUGOGO protocols for moderate-severe disease), orbital radiotherapy as an adjunct, and IGF-1R inhibition (teprotumumab) where available; rituximab evidence is mixed.
- Decompression options and their millimetre yields: orbital fat removal alone (about 2-5 mm reduction), medial wall decompression (ethmoid, about 3-4 mm), lateral wall decompression (about 2-4 mm, lowest new-diplopia risk), orbital floor (largest reduction, highest risk of hypoglobus and new diplopia), and balanced medial-plus-lateral decompression — the modern preference that preserves ocular alignment.
- Indications for decompression: compressive optic neuropathy (urgent), corneal exposure unrelieved by lubricants and tarsorrhaphy, severe proptosis with pain or globe subluxation, and rehabilitative cosmesis in the inactive phase.
- The fixed surgical sequence: orbital decompression first, then strabismus surgery for resultant diplopia (at least 3-6 months later, once alignment stabilises), then eyelid surgery (retraction repair) last — reversing the order undoes each step.
- Complications to quote: new or worsened diplopia (the commonest significant one), infraorbital nerve numbness, CSF leak, orbital haemorrhage with visual loss, and lid crease asymmetry.
Why the apex decides the urgency
A 46-year-old woman with Graves disease notices colours fading — red desaturates first — with a dull retrobulbar ache on upgaze; acuity is 6/6 bilaterally, but visual fields show central scotomas and orbital CT reveals massively enlarged medial and inferior recti crowding the orbital apex. She is within the active inflammatory phase, yet this presentation cannot wait for the burnt-out phase: dysthyroid optic neuropathy is graded by colour vision and fields, not acuity, and decompression is sight-saving. The operation chosen is endoscopic endonasal medial wall decompression — the ethmoid sinus is entered through the nose, the lamina papyracea removed, periorbita opened, and the swollen bellies of the medial rectus decompress into the sinus space — combined with fat removal; the lateral wall may be added for balance, reducing the chance of new vertical diplopia. Colour vision recovers within weeks. Had she instead presented with stable, disfiguring 28 mm proptosis after two years of quiescence, the same operation would be elective and rehabilitative — balanced two-wall decompression, then squint and lid surgery sequenced afterwards. One operation, two utterly different triggers: an apex under pressure commands immediacy, while a settled, swollen orbit commands planning.
Where students slip
Students time decompression by the activity score alone and watch an optic nerve strangle through an "active" phase — the exception is that sight-threatening disease is decompressed regardless of activity. The second slip is sequence: promising lid surgery before strabismus work, or squint surgery before decompression settles the muscle positions, guarantees reoperations. Students also overstate the cure — decompression reduces proptosis and saves the nerve but commonly trades a few millimetres for diplopia risk, which consent must mention. In vivas, quote the apical-crowding mechanism, colour desaturation as the early sign, and balanced medial-lateral decompression as the diplopia-sparing modern choice.
Frequently asked questions
When is orbital decompression urgent?
In compressive dysthyroid optic neuropathy — apical crowding with colour desaturation and field loss — and in severe exposure keratopathy, regardless of disease activity phase.
Why must decompression precede squint and eyelid surgery?
Decompression changes muscle positions and lid levels, so alignment and retraction are corrected only after the orbit settles; reversing the sequence wastes each operation.
What is balanced orbital decompression?
Combined medial and lateral wall removal, expanding the orbit symmetrically to reduce proptosis while lowering the risk of new postoperative diplopia.
How much proptosis reduction does decompression achieve?
Fat removal gives about 2-5 mm, individual walls 3-4 mm, and combined multi-wall approaches up to 8-12 mm in severe cases.
What medical therapies precede or accompany it?
Smoking cessation, intravenous methylprednisolone per EUGOGO protocols, orbital radiotherapy as adjunct, and IGF-1R antibodies such as teprotumumab where accessible.